Assessment of disease behavior in patients with crohn's disease by MR enterography

Inflammatory Bowel Diseases

Volumn 19, Issue 5, 2013, Pages 983-990

  Schill, Gabriela ^a   Iesalnieks, Igors ^b   Haimerl, Michael ^a   Müller Wille, René ^a   Dendl, Lena Marie ^a   Wiggermann, Philipp ^a   Schleder, Stephan ^a   Rennert, Janine ^a   Ott, Claudia ^a   Agha, Ayman ^a   Stroszczynski, Christian ^a   Schreyer, Andreas G ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Marienhospital ^*  (Germany)

Author keywords

Classification; Crohn's disease; Mri

Indexed keywords

ABSCESS; ADOLESCENT; ADULT; AGED; ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; MAGNETIC RESONANCE ENTEROGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANASTOMOSIS, SURGICAL; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; INTESTINES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84876369229     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31828029dd     Document Type: Article

References (32)

1. Crama-Bohbouth G, Pena AS, Biemond I, et al. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease? Gut. 1989;30:1236-1240.
2. Freeman HJ. Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol. 2008;14:4127-4130.
3. Gasche C, Schölmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
4. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.
5. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
6. Iesalnieks I, Kilger A, Glass H, et al. Perforating Crohn's ileitis: delay of surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis. 2010;16:2125-2130.
7. Friedrich C, Fajfar A, Pawlik M, et al. Magnetic resonance enterography with and without biphasic contrast agent enema compared to conventional ileocolonoscopy in patients with Crohn's disease. Inflamm Bowel Dis. 2012; 18:1842-1848.
8. Schreyer AG, Seitz J, Feuerbach S, et al. Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD). Inflamm Bowel Dis. 2004;10:45-54.
9. Schreyer AG, Golder S, Scheibl K, et al. Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: first clinical experience. Inflamm Bowel Dis. 2005;11:388-394.
10. Schreyer AG, Scheibl K, Heiss P, et al. MR colonography in inflammatory bowel disease. Abdom Imaging. 2006;31:302-307.
11. Schreyer AG, Menzel C, Friedrich C, et al. Comparison of high-resolution ultrasound and MR-enterography in patients with inflammatory bowel disease. World J Gastroenterol. 2011;17:1018-1025.
12. Girlich C, Ott C, Strauch U, et al. Clinical feature and bowel ultrasound in Crohn's disease-does additional information from magnetic resonance imaging affect therapeutic approach and when does extended diagnostic investigation make sense? Digestion. 2011;83:18-23.
13. Hoffmann JC, Preiss JC, Autschbach F, et al. Clinical practice guideline on diagnosis and treatment of Crohn's disease. Z Gastroenterol. 2008;46: 1094-1146.
14. Schreyer AG, Ludwig D, Koletzko S, et al. Updated German S3-guideline regarding the diagnosis of Crohn's disease-implementation of radiological modalities. Rofo. 2010;182:116-121.
15. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607.
16. Van Assche G, Dignass A, Panes J, et al. The second European evidencebased Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7-27.
17. Chiorean MV, Sandrasegaran K, Saxena R, et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol. 2007;102:2541-2550.
18. Ajaj W, Goehde SC, Schneemann H, et al. Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol. 2004;14:458-464.
19. Schreyer AG, Geissler A, Albrich H, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol. 2004;2:491-497.
20. Schreyer AG, Hoffstetter P, Daneschnejad M, et al. Comparison of conventional abdominal CT with MR-enterography in patients with active Crohn's disease and acute abdominal pain. Acad Radiol. 2010;17:352-357.
21. Rieber A, Nussle K, Reinshagen M, et al. MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging. 2002;27:394-399.
22. Masselli G, Casciani E, Polettini E, et al. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol. 2008;18:438-447.
23. Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247:64-79.
24. Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of (18) F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis. 2012;18: 2252-2260.
25. Onali S, Calabrese E, Pallone F. Measuring disease activity in Crohn's disease. Abdom Imaging. 2012;37:927-932.
26. Vilela EG, Torres HO, Martins FP, et al. Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis. World J Gastroenterol. 2012;18:872-881.
27. Oto A, Kayhan A, Williams JT, et al. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging. 2011;33:615-624.
28. StewardMJ, Punwani S, Proctor I, et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol. 2011;81:2080-2088.
29. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology. 2009;252:712-720.
30. Hafeez R, Punwani S, Boulos P, et al. Diagnostic and therapeutic impact of MR enterography in Crohn's disease. Clin Radiol. 2011;66:1148-1158.
31. Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007;50:331-336.
32. Schmidt T, Reinshagen M, Brambs HJ, et al. Comparison of conventional enteroclysis, intestinal ultrasound and MRI-enteroclysis for determining changes in the small intestine and complications in patients with Crohn's disease. Z Gastroenterol. 2003;41:641-648.